DIN 02563444 — HYRNUO 10 MG
HYRNUO is a tablet of Sevabertinib marketed by BAYER INC. The full Sevabertinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02563444
- Brand name
- HYRNUO
- Active ingredient
- Sevabertinib
- Strength
- 10 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BAYER INC
- Health Canada status
- MARKETED
- Drug class
- HER2 (ERBB2) tyrosine kinase inhibitor (protein kinase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.